Lung Neoplasm
Oncology
2
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
DS
Heidelberg PharmaGermany - Ladenburg
1 programLungPoint Virtual Bronchoscopic NavigationN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Daiichi SankyoR-DXD
Blueprint MedicinesBLU-701
Heidelberg PharmaLungPoint Virtual Bronchoscopic Navigation
Clinical Trials (3)
Total enrollment: 224 patients across 3 trials
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Start: May 2025Est. completion: Mar 2032144 patients
Phase 2Recruiting
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC
Start: Jan 2022Est. completion: Dec 202220 patients
Phase 1Terminated
Evaluation of the LungPoint Virtual Bronchoscopic Navigation (VBN) System
Start: Jul 2009Est. completion: Mar 201160 patients
N/AUnknown
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
1m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
1m ago
Office Administrator
SystImmune
1m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
11m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
15m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
15m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 224 patients
3 companies competing in this space